Veru, Inc. (VERU)
2.625
-0.12
(-4.20%)
USD |
NASDAQ |
Aug 28, 16:00
2.64
+0.02
(+0.57%)
After-Hours: 20:00
Veru Cash and Short Term Investments (Quarterly) : 25.79M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.79M |
| March 31, 2026 | 30.76M |
| December 31, 2025 | 35.40M |
| September 30, 2025 | 18.32M |
| June 30, 2025 | 15.01M |
| March 31, 2025 | 20.02M |
| December 31, 2024 | 26.61M |
| September 30, 2024 | 25.66M |
| June 30, 2024 | 29.15M |
| March 31, 2024 | 34.74M |
| December 31, 2023 | 40.58M |
| September 30, 2023 | 9.626M |
| June 30, 2023 | 16.21M |
| March 31, 2023 | 23.50M |
| December 31, 2022 | 46.93M |
| September 30, 2022 | 80.19M |
| June 30, 2022 | 100.55M |
| March 31, 2022 | 112.02M |
| December 31, 2021 | 116.10M |
| September 30, 2021 | 122.36M |
| June 30, 2021 | 123.16M |
| March 31, 2021 | 136.68M |
| December 31, 2020 | 30.92M |
| September 30, 2020 | 13.59M |
| June 30, 2020 | 15.39M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.558M |
| December 31, 2019 | 4.175M |
| September 30, 2019 | 6.295M |
| June 30, 2019 | 8.039M |
| March 31, 2019 | 5.896M |
| December 31, 2018 | 8.979M |
| September 30, 2018 | 3.760M |
| June 30, 2018 | 5.577M |
| March 31, 2018 | 8.972M |
| December 31, 2017 | 3.572M |
| September 30, 2017 | 3.278M |
| June 30, 2017 | 2.671M |
| March 31, 2017 | 1.242M |
| December 31, 2016 | 3.485M |
| September 30, 2016 | 2.385M |
| June 30, 2016 | 3.211M |
| March 31, 2016 | 2.791M |
| December 31, 2015 | 3.672M |
| September 30, 2015 | 4.106M |
| June 30, 2015 | 2.625M |
| March 31, 2015 | 2.934M |
| December 31, 2014 | 4.569M |
| September 30, 2014 | 5.796M |
| June 30, 2014 | 4.142M |
| March 31, 2014 | 5.941M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 375.87M |
| Corcept Therapeutics, Inc. | 308.20M |
| Johnson & Johnson | 20.76B |
| Eli Lilly & Co. | 8.95B |
| Lexicon Pharmaceuticals, Inc. | 190.61M |